loading

なぜGain Therapeutics Inc(GANX)の株価が下がっていますか?

2026-03-03 の取引セッション中に、Gain Therapeutics Inc (GANX) 株の 5.17% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。
2023-11-21:

Gain Therapeutics Inc Stock (GANX) dropped by 23.90% from $2.72 to $2.07 in the trading on Tuesday November 21, 2023. The reason why GANX stock down today is due to the announcement of public offering. Gain Therapeutics has announced pricing of $9.4 million public offering of 2,213,044 shares at $2.005/share and accompanying warrants. In connection with the offering, Gain has granted the underwriters a 30-day option to purchase up to an additional 15% of shares of common stock and/or warrants

$98.89
price down icon 1.19%
$51.05
price down icon 3.39%
$47.52
price down icon 0.08%
$103.83
price down icon 3.34%
$148.00
price up icon 1.03%
biotechnology ONC
$300.59
price down icon 4.91%
大文字化:     |  ボリューム (24 時間):